The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Distress Syndrome Market Research Report 2025
Synopsis
The global market for Respiratory Distress Syndrome was valued at US$ 420 million in the year 2024 and is projected to reach a revised size of US$ 608 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome.
The Respiratory Distress Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Segment by Type
Poractant Alfa
Beractant
Calfactant
Others
Segment by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Distress Syndrome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Respiratory Distress Syndrome was valued at US$ 420 million in the year 2024 and is projected to reach a revised size of US$ 608 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome.
The Respiratory Distress Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Segment by Type
Poractant Alfa
Beractant
Calfactant
Others
Segment by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Distress Syndrome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Distress Syndrome Market Perspective (2020-2031)
2.2 Global Respiratory Distress Syndrome Growth Trends by Region
2.2.1 Global Respiratory Distress Syndrome Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Respiratory Distress Syndrome Historic Market Size by Region (2020-2025)
2.2.3 Respiratory Distress Syndrome Forecasted Market Size by Region (2026-2031)
2.3 Respiratory Distress Syndrome Market Dynamics
2.3.1 Respiratory Distress Syndrome Industry Trends
2.3.2 Respiratory Distress Syndrome Market Drivers
2.3.3 Respiratory Distress Syndrome Market Challenges
2.3.4 Respiratory Distress Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Distress Syndrome Players by Revenue
3.1.1 Global Top Respiratory Distress Syndrome Players by Revenue (2020-2025)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2020-2025)
3.2 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Respiratory Distress Syndrome Revenue
3.4 Global Respiratory Distress Syndrome Market Concentration Ratio
3.4.1 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Distress Syndrome Revenue in 2024
3.5 Global Key Players of Respiratory Distress Syndrome Head office and Area Served
3.6 Global Key Players of Respiratory Distress Syndrome, Product and Application
3.7 Global Key Players of Respiratory Distress Syndrome, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Distress Syndrome Breakdown Data by Type
4.1 Global Respiratory Distress Syndrome Historic Market Size by Type (2020-2025)
4.2 Global Respiratory Distress Syndrome Forecasted Market Size by Type (2026-2031)
5 Respiratory Distress Syndrome Breakdown Data by Application
5.1 Global Respiratory Distress Syndrome Historic Market Size by Application (2020-2025)
5.2 Global Respiratory Distress Syndrome Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Respiratory Distress Syndrome Market Size (2020-2031)
6.2 North America Respiratory Distress Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Respiratory Distress Syndrome Market Size by Country (2020-2025)
6.4 North America Respiratory Distress Syndrome Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Distress Syndrome Market Size (2020-2031)
7.2 Europe Respiratory Distress Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Respiratory Distress Syndrome Market Size by Country (2020-2025)
7.4 Europe Respiratory Distress Syndrome Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Distress Syndrome Market Size (2020-2031)
8.2 Asia-Pacific Respiratory Distress Syndrome Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2020-2025)
8.4 Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Distress Syndrome Market Size (2020-2031)
9.2 Latin America Respiratory Distress Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Respiratory Distress Syndrome Market Size by Country (2020-2025)
9.4 Latin America Respiratory Distress Syndrome Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Distress Syndrome Market Size (2020-2031)
10.2 Middle East & Africa Respiratory Distress Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2020-2025)
10.4 Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Introduction
11.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.1.5 Chiesi Farmaceutici Recent Development
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Details
11.2.2 CR-Double Crane Business Overview
11.2.3 CR-Double Crane Respiratory Distress Syndrome Introduction
11.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.2.5 CR-Double Crane Recent Development
11.3 ONY Biotech
11.3.1 ONY Biotech Company Details
11.3.2 ONY Biotech Business Overview
11.3.3 ONY Biotech Respiratory Distress Syndrome Introduction
11.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.3.5 ONY Biotech Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Respiratory Distress Syndrome Introduction
11.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.4.5 AbbVie Recent Development
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Details
11.5.2 Yuhan Corporation Business Overview
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Introduction
11.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.5.5 Yuhan Corporation Recent Development
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Details
11.6.2 JW Pharmaceuticals Business Overview
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Introduction
11.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.6.5 JW Pharmaceuticals Recent Development
11.7 Noargen
11.7.1 Noargen Company Details
11.7.2 Noargen Business Overview
11.7.3 Noargen Respiratory Distress Syndrome Introduction
11.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2020-2025)
11.7.5 Noargen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Poractant Alfa
Table 3. Key Players of Beractant
Table 4. Key Players of Calfactant
Table 5. Key Players of Others
Table 6. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Respiratory Distress Syndrome Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Respiratory Distress Syndrome Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Respiratory Distress Syndrome Market Share by Region (2020-2025)
Table 10. Global Respiratory Distress Syndrome Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Respiratory Distress Syndrome Market Share by Region (2026-2031)
Table 12. Respiratory Distress Syndrome Market Trends
Table 13. Respiratory Distress Syndrome Market Drivers
Table 14. Respiratory Distress Syndrome Market Challenges
Table 15. Respiratory Distress Syndrome Market Restraints
Table 16. Global Respiratory Distress Syndrome Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Respiratory Distress Syndrome Market Share by Players (2020-2025)
Table 18. Global Top Respiratory Distress Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2024)
Table 19. Ranking of Global Top Respiratory Distress Syndrome Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Respiratory Distress Syndrome Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Respiratory Distress Syndrome, Headquarters and Area Served
Table 22. Global Key Players of Respiratory Distress Syndrome, Product and Application
Table 23. Global Key Players of Respiratory Distress Syndrome, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Distress Syndrome Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
Table 27. Global Respiratory Distress Syndrome Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Respiratory Distress Syndrome Revenue Market Share by Type (2026-2031)
Table 29. Global Respiratory Distress Syndrome Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
Table 31. Global Respiratory Distress Syndrome Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Respiratory Distress Syndrome Revenue Market Share by Application (2026-2031)
Table 33. North America Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Respiratory Distress Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Respiratory Distress Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Respiratory Distress Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Respiratory Distress Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Respiratory Distress Syndrome Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Respiratory Distress Syndrome Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Respiratory Distress Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Respiratory Distress Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Respiratory Distress Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 48. Chiesi Farmaceutici Company Details
Table 49. Chiesi Farmaceutici Business Overview
Table 50. Chiesi Farmaceutici Respiratory Distress Syndrome Product
Table 51. Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 52. Chiesi Farmaceutici Recent Development
Table 53. CR-Double Crane Company Details
Table 54. CR-Double Crane Business Overview
Table 55. CR-Double Crane Respiratory Distress Syndrome Product
Table 56. CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 57. CR-Double Crane Recent Development
Table 58. ONY Biotech Company Details
Table 59. ONY Biotech Business Overview
Table 60. ONY Biotech Respiratory Distress Syndrome Product
Table 61. ONY Biotech Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 62. ONY Biotech Recent Development
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Respiratory Distress Syndrome Product
Table 66. AbbVie Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Yuhan Corporation Company Details
Table 69. Yuhan Corporation Business Overview
Table 70. Yuhan Corporation Respiratory Distress Syndrome Product
Table 71. Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 72. Yuhan Corporation Recent Development
Table 73. JW Pharmaceuticals Company Details
Table 74. JW Pharmaceuticals Business Overview
Table 75. JW Pharmaceuticals Respiratory Distress Syndrome Product
Table 76. JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 77. JW Pharmaceuticals Recent Development
Table 78. Noargen Company Details
Table 79. Noargen Business Overview
Table 80. Noargen Respiratory Distress Syndrome Product
Table 81. Noargen Revenue in Respiratory Distress Syndrome Business (2020-2025) & (US$ Million)
Table 82. Noargen Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Respiratory Distress Syndrome Picture
Figure 2. Global Respiratory Distress Syndrome Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Respiratory Distress Syndrome Market Share by Type: 2024 VS 2031
Figure 4. Poractant Alfa Features
Figure 5. Beractant Features
Figure 6. Calfactant Features
Figure 7. Others Features
Figure 8. Global Respiratory Distress Syndrome Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Respiratory Distress Syndrome Market Share by Application: 2024 VS 2031
Figure 10. Very Preterm Infants Case Studies
Figure 11. Moderate to Late Preterm Infants Case Studies
Figure 12. Others Case Studies
Figure 13. Respiratory Distress Syndrome Report Years Considered
Figure 14. Global Respiratory Distress Syndrome Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Respiratory Distress Syndrome Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Respiratory Distress Syndrome Market Share by Region: 2024 VS 2031
Figure 17. Global Respiratory Distress Syndrome Market Share by Players in 2024
Figure 18. Global Top Respiratory Distress Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2024
Figure 20. North America Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Respiratory Distress Syndrome Market Share by Country (2020-2031)
Figure 22. United States Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Respiratory Distress Syndrome Market Share by Country (2020-2031)
Figure 26. Germany Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Respiratory Distress Syndrome Market Share by Region (2020-2031)
Figure 34. China Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Respiratory Distress Syndrome Market Share by Country (2020-2031)
Figure 42. Mexico Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Respiratory Distress Syndrome Market Share by Country (2020-2031)
Figure 46. Turkey Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Respiratory Distress Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Chiesi Farmaceutici Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 50. CR-Double Crane Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 51. ONY Biotech Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 52. AbbVie Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 53. Yuhan Corporation Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 54. JW Pharmaceuticals Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 55. Noargen Revenue Growth Rate in Respiratory Distress Syndrome Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
